Status:

COMPLETED

Treating COVID-19 With a Bidirectional Oxygenation Valve

Lead Sponsor:

TMC HealthCare

Collaborating Sponsors:

PEEP Medical, LLC

Conditions:

Coronavirus Infection

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will utilize a single center internal control study design. The objective of this study is to determine the feasibility and safety of a bidirectional oxygenation PEEP generating mouthpiece ...

Detailed Description

We have developed a simple and straightforward silicone rubber-made oral appliance that promotes positive expiratory airway pressures with the potential to enhance respiratory function while preventin...

Eligibility Criteria

Inclusion

  • Oxygen saturation \<93%
  • Able to provide informed consent
  • Not currently requiring intubation
  • Receiving oxygen by face mask

Exclusion

  • Unable or unwilling to provide informed consent, cognitive impairment
  • Rapidly decompensating status requiring urgent or emergent higher level of care

Key Trial Info

Start Date :

March 27 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 27 2021

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04326452

Start Date

March 27 2020

End Date

March 27 2021

Last Update

May 4 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

TMC HealthCare

Tucson, Arizona, United States, 85712

2

Stanford University

Stanford, California, United States, 94305

3

Emory Saint Joseph's Hospital

Atlanta, Georgia, United States, 30342